Industry News

Keep up to date with the latest news and information from Medilink West Midlands and our members across the Medical Technology and Life Science sectors, together with topical regional, national and international news.

Filter by date:

DEMAND Hub (Data-Enabled Medical technologies And Devices Hub)

Featured News
18th October 2021

DEMAND Hub (Data-Enabled Medical technologies ANd Devices Hub) is an ERDF-supported programme for the Black Country, Greater Birmingham and Solihull, Coventry & Warwickshire, and Stoke-On-Trent & Staffordshire LEP regions. The programme is now live as of 1 July 2020. The programme will run until June 2023 and supports SME businesses in, or looking to enter, the healthcare […]

Diagnostic technology company secures £800k for point of care diagnostics platform

Featured News
25th February 2021

Former Medilink member, Birmingham-based Linear Diagnostics Ltd has secured £800,000 from the Midlands Engine Investment Fund (MEIF) and other investors in the company’s second round of funding, which will enable the company to commence the development of the hardware platform for its tests. The finance will facilitate the ongoing development of the company’s high-speed platform technology for point of […]

New COVID-19 RNA test gives accurate results within minutes

Featured News
7th January 2021

University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under five, and delivers accurate results. The method is described in a preprint paper (yet to be peer-reviewed) published on MedRxiv, where the researchers also demonstrate the rapidity and sensitivity of their method using patient sample RNA provided by […]

Magnetic brain waves to detect injury and disease

Featured News
25th November 2020

Scientists at the University of Birmingham have developed a new sensor to measure weak magnetic signals in the brain, which has the potential to increase understanding of connectivity in the brain, and detect signs of traumatic brain injury, dementia and schizophrenia.  Magnetic signals in the brain are measured by magnetoencephalography (MEG).  They are easier to […]

UoB researchers design a new approach to treating cancers and other diseases

Featured News
25th November 2020

A new approach to treating cancers and other diseases that uses a mechanically interlocked molecule as a ‘magic bullet’ has been designed by researchers at the University of Birmingham. Called rotaxanes, the molecules are tiny nanoscale structures that resemble a dumbbell with a ring trapped around the central post.  Scientists have been experimenting with rotaxanes […]

Medilink member develop Anti-COVID-19 nasal spray ‘ready for use in humans’

Featured News
19th November 2020

A nasal spray that can provide effective protection against the COVID-19 virus has been developed by researchers at the University of Birmingham, using materials already cleared for use in humans. A team in the University’s Healthcare Technologies Institute formulated the spray using compounds already widely approved by regulatory bodies in the UK, Europe and the […]

New mouth spray could benefit patients with painful genetic skin condition

Featured News
2nd November 2020

A new spray for treating severely painful blisters, mouth ulceration and oral scarring in patients with a rare genetic skin condition is being developed by researchers at the University of Birmingham. The spray is designed for patients with Epidermolysis Bullosa (EB), a condition that causes the skin to blister and tear at the slightest touch. […]

New Device for Detecting Traumatic Brain Injury ‘On the Spot’

Featured News
16th October 2020

A method for detecting traumatic brain injury at the point of care has been developed by scientists at the University of Birmingham. Using chemical biomarkers released by the brain immediately after a head injury occurs, researchers are able to pinpoint when patients need urgent medical attention. This saves time in delivering vital treatment and avoids […]

Funding boost for AI-based epilepsy monitoring

Featured News
8th September 2020

Today, Medilink member the University of Birmingham shares the amazing news, its spinout company Neuronostics has been awarded £720,000 of government funding to fund the development of its first prototype clinical platform – developing the software that will bring BioEP technology safely and securely into the clinic. 

Birmingham spinout announces collaboration and licence agreement to develop precision cancer treatments

Featured News
21st July 2020

Established in 2014 by Cancer Research Technologies and Medilink member, the University of Birmingham, Birmingham spinout Revitope Oncology Inc has announced a research collaboration and license agreement with leading Chinese biopharmaceutical company Junshi Biosciences to develop precision cancer therapies that harness the body’s immune response to kill cancer cells while leaving healthy body tissues untouched.

  • 1
  • 2

Sign Up to receive our newsletter

© Medilink WM. All rights reserved.

Created by Gritt and Co